Join Our 20,000+ Subscribers. Get Weekly News Sent To Your Email
Subscribe to our newsletter and stay updated on the latest Critical Care Medicine related news.
See Past Critical Care Newsletter issues

Subscribe to Newsletter

Cefiderocol, A Novel Investigational Siderophore Cephalosporin, Demonstrated Potent Activity Against Multi-Drug Resistant Gram-Negative Pathogens

shionogi.com October 28, 2016

carbapenem-resistant

Cefiderocol showed potent activity against Gram-negative pathogens, including carbapenem-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii as well as carbapenem-resistant Enterobacteriaceae. The results were presented using in vitro data from 8765 test strains of P. aeruginosa, A. baumannii, and Enterobacteriaceae.

drugs FDA infection pathogens study

Early Antiviral Use and Supplemental Oxygen Decrease the Risk of Secondary Bacterial Infections

Cardiac Damage in Patients Infected with Different COVID-19 Variants of Concern

Long-term Prevalence of PTSD Symptom in Family Members of Severe COVID-19 Patients

Two Biomarkers Improve CRB-65 Predictability for Death Due to Community-Acquired Pneumonia

Harrison’s Pulmonary and Critical Care Medicine

When the Air Hits Your Brain: Tales from Neurosurgery

The Very Old Critically Ill Patients (Lessons from the ICU)

RRT Board Exam: Mechanical Ventilation

The Practice and Principles of Extra-Corporeal Membrane Oxygenation (ECMO)

Case Files Emergency Medicine, Fourth Edition

Identification of Biomarkers, New Treatments, and Vaccines for COVID-19

Hemodynamic Monitoring Using Echocardiography in the Critically Ill

Bedside Procedures in the ICU

Severe Trauma and Sepsis: Organ Damage and Tissue Repair

Evidence-Based Critical Care: A Case Study Approach

Trauma Team Dynamics: A Trauma Crisis Resource Management Manual

ECMO in the Adult Patient (Core Critical Care)

COVID-19 and the Cardiovascular System: From Pathophysiology to Clinical Management